A significant breakthrough in cancer research is occurring with the use of nanobodies to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently disabled in various forms of malignancies, https://funbookmarking.com/story21946134/nanobodies-revive-p53-new-new-pathway-for-tumor-treatment